Aim: The aim of the present study was to assess the illness details and treatment related details. Methods: The cross-sectional study was conducted at Dr. D. Y. Patil Medical College, Hospital and Research centre, Pimpri, Pune from July 2015 to September 2017 and 126 patients were included in the study. Results: The majority of patients 78(61.9%) were in the age group of less than 40 years and there were 48(38.1%) cases who were aged more than 40 years. Majority of cases were females 67(53.2%) and 59(46.8%) cases were males. 89 (70.63%) patients who were not having past history of psychiatric illness and 37(29.37%) were having past history of psychiatric illness. 114 patients (90.48%) were not having past history of medical illness and 12(9.52%) were having past history of medical illness. there were 107(84.92%) cases who were having no family history of psychiatric illness and 19(15.08%) cases who were having family history of psychiatric illness. The patients who were taking treatment in that there were 46(51.7%) cases who were taking antipsychotics, 19(21.3%) was taking antidepressants,11(12.4%) cases were taking both antipsychotics and mood stabilizers,9(10.1%) were taking other drugs followed by 4(4.5%) taking mood stabilizers.56(62.9%) cases were taking treatment for ≥3 months and 33(37.1%) cases were taking it for <3months. Conclusion: The study suggests that patients suffering from psychiatric disorders are at higher risk of developing metabolic syndrome. The Framingham risk score and 10 years coronary heart disease risk was also found to be higher in these patients. The factors which were found to be responsible for high risk of metabolic syndrome in psychiatric disorders were older age, female gender, schizophrenia, antipsychotic drugs class and its duration of use (≥3mnths), family history of psychiatric illness, low physical activity, increased frequency of substance use and deranged metabolic parameters.